Concomitant use of clopidogrel and PPIs increases risk of adverse outcomes

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2009年 / 1243卷 / 1期
关键词：
Myocardial Infarction; Acute Coronary Syndrome; Clopidogrel; Secondary Outcome; Hospital Discharge;
D O I：
10.2165/00128415-200912430-00003
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [21] Concomitant Use of Medications increases the Risk of Fractures
    Di Lellis, Maddalena Angela
    AKTUELLE RHEUMATOLOGIE, 2021, 46 (05) : 433 - +
  • [22] PPI use increases risk of liver-related adverse outcomes in cirrhosis
    Reactions Weekly, 2022, 1903 (1) : 11 - 11
  • [23] Adverse Outcomes Associated With Use of Proton Pump Inhibitors and Clopidogrel
    Hayes, Stephen
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (01): : 30 - 31
  • [24] Long-term Impact of Concomitant Use of Proton Pump Inhibitors (PPIs) and Clopidogrel Following Percutaneous Coronary Intervention
    Aref, Subhi J.
    Kim, Luke
    Minutello, Robert M.
    Undemir, Cenap
    Bergman, Geoffrey
    Wong, S. Chiu
    Feldman, Dmitriy N.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (13) : B92 - B92
  • [25] Adverse Outcomes Associated With Use of Proton Pump Inhibitors and Clopidogrel Reply
    Ho, P. Michael
    Rumsfeld, John S.
    Wang, Li
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (01): : 31 - 31
  • [26] Treatment with losartan increases risk of adverse renal outcomes
    Claire Greenhill
    Nature Reviews Endocrinology, 2011, 7 (1) : 2 - 2
  • [27] Childhood Abuse Increases Risk of Adverse Perinatal Outcomes
    Johnson, Quinetta
    Bush, Heather
    Coker, Ann
    OBSTETRICS AND GYNECOLOGY, 2018, 131 : 70S - 70S
  • [28] RISK OF RECURRENT MYOCARDIAL INFARCTION WITH THE CONCOMITANT USE OF CLOPIDOGREL AND PROTON PUMP INHIBITORS
    Valkhoff, V. E.
    Jong, G. W.
    van Soest, E. M.
    Kuipers, E. J.
    Sturkenboom, M. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S9 - S9
  • [29] Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors
    Valkhoff, V. E.
    't Jong, G. W.
    van Soest, E. M.
    Kuipers, E. J.
    Sturkenboom, M. C. J. M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (01) : 77 - 88
  • [30] Increased risk of adverse events with concomitant use of atorvastatin and thiazolidinediones
    Alsheikh-Ali, AA
    Karas, RH
    CIRCULATION, 2003, 108 (17) : 736 - 737
12345